Literature DB >> 20668203

Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding.

Elizabeth S Maywood1, Eloise Fraenkel, Catherine J McAllister, Nigel Wood, Akhilesh B Reddy, Michael H Hastings, A Jennifer Morton.   

Abstract

Behavioral circadian rhythms disintegrate progressively in the R6/2 mouse model of Huntington's disease (HD), recapitulating the sleep-wake disturbance seen in HD patients. Here we show that disturbances in circadian pacemaking are not restricted to the brain, but also encompass peripheral metabolic pathways in R6/2 mice. Notably, circadian rhythms of clock-driven genes that are key metabolic outputs in the liver are abolished in vivo. This deficiency is accompanied by arrhythmic expression of the clock genes Cry1 and Dbp, and a phase-advanced Per2 cycle. Compromised circadian metabolic cycles are not, however, a consequence of deficient pacemaking intrinsic to the liver, because when cultured in vitro, R6/2 liver slices exhibit self-sustained circadian bioluminescence rhythms. We therefore propose that compromised metabolic cycles arise from an internal desynchronization secondary to altered feeding patterns and impaired circadian signaling from the central pacemaker of the suprachiasmatic nucleus (SCN). Importantly, the SCN-independent food-entrainable oscillator remains intact in R6/2 mice and, when invoked, can restore daily behavioral cycles and reverse some of the metabolic abnormalities seen in the liver. Disturbances of metabolism have long been thought to be an important feature of HD. Uncoupling liver metabolism from circadian drives will reduce metabolic efficiency and cause imbalances in metabolites known to be deleterious to brain function. Thus, even subtle imbalances in liver function may exacerbate symptoms of HD, where neurological function is already compromised.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668203      PMCID: PMC6633357          DOI: 10.1523/JNEUROSCI.1694-10.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  26 in total

1.  Formation of polyglutamine inclusions in non-CNS tissue.

Authors:  K Sathasivam; C Hobbs; M Turmaine; L Mangiarini; A Mahal; F Bertaux; E E Wanker; P Doherty; S W Davies; G P Bates
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

2.  Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.

Authors:  Jürgen Andrich; Carsten Saft; Anneliese Arz; Birgit Schneider; Markus W Agelink; Peter H Kraus; Wilfried Kuhn; Thomas Müller
Journal:  Mov Disord       Date:  2004-02       Impact factor: 10.338

3.  Circadian rhythms: per2bations in the liver clock.

Authors:  Akhilesh B Reddy; Elizabeth S Maywood
Journal:  Curr Biol       Date:  2007-04-17       Impact factor: 10.834

4.  Resetting central and peripheral circadian oscillators in transgenic rats.

Authors:  S Yamazaki; R Numano; M Abe; A Hida; R Takahashi; M Ueda; G D Block; Y Sakaki; M Menaker; H Tei
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

5.  The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.

Authors:  Ming-Chang Chiang; Hui-Mei Chen; Hsing-Lin Lai; Hsiao-Wen Chen; Szu-Yi Chou; Chiung-Mei Chen; Fuu-Jen Tsai; Yijuang Chern
Journal:  Hum Mol Genet       Date:  2009-05-14       Impact factor: 6.150

6.  Sleep patterns in patients with Huntington's disease and their unaffected first-degree relatives: a brief report.

Authors:  Miroslav Cuturic; Ruth K Abramson; Daniel Vallini; Elaine M Frank; Morteza Shamsnia
Journal:  Behav Sleep Med       Date:  2009       Impact factor: 2.964

7.  Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease.

Authors:  Patrick N Pallier; A Jennifer Morton
Journal:  Brain Res       Date:  2009-05-18       Impact factor: 3.252

8.  S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism.

Authors:  Ivo Baric; Ksenija Fumic; Byron Glenn; Mario Cuk; Andreas Schulze; James D Finkelstein; S Jill James; Vlatka Mejaski-Bosnjak; Leo Pazanin; Igor P Pogribny; Marko Rados; Vladimir Sarnavka; Mira Scukanec-Spoljar; Robert H Allen; Sally Stabler; Lidija Uzelac; Oliver Vugrek; Conrad Wagner; Steven Zeisel; S Harvey Mudd
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

9.  Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.

Authors:  Hilary Moffitt; Graham D McPhail; Ben Woodman; Carl Hobbs; Gillian P Bates
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

10.  Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease.

Authors:  Patrick N Pallier; Elizabeth S Maywood; Zhiguang Zheng; Johanna E Chesham; Alexei N Inyushkin; Richard Dyball; Michael H Hastings; A Jennifer Morton
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

View more
  60 in total

1.  Journal club. A chronobiologist makes sense of circadian dysfunction in illness.

Authors:  Martha Merrow
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

Review 2.  Commentary: the year in circadian rhythms.

Authors:  Paolo Sassone-Corsi
Journal:  Mol Endocrinol       Date:  2010-10-06

3.  Dysfunctions in circadian behavior and physiology in mouse models of Huntington's disease.

Authors:  Takashi Kudo; Analyne Schroeder; Dawn H Loh; Dika Kuljis; Maria C Jordan; Kenneth P Roos; Christopher S Colwell
Journal:  Exp Neurol       Date:  2010-12-22       Impact factor: 5.330

4.  How to fix a broken clock.

Authors:  Analyne M Schroeder; Christopher S Colwell
Journal:  Trends Pharmacol Sci       Date:  2013-10-10       Impact factor: 14.819

Review 5.  Linking neural activity and molecular oscillations in the SCN.

Authors:  Christopher S Colwell
Journal:  Nat Rev Neurosci       Date:  2011-09-02       Impact factor: 34.870

6.  Direct regulation of diurnal Drd3 expression and cocaine reward by NPAS2.

Authors:  Angela R Ozburn; Edgardo Falcon; Alan Twaddle; Alexandria L Nugent; Andrea G Gillman; Sade M Spencer; Rachel N Arey; Shibani Mukherjee; James Lyons-Weiler; David W Self; Colleen A McClung
Journal:  Biol Psychiatry       Date:  2014-08-13       Impact factor: 13.382

7.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

Review 8.  Aging and the clock: Perspective from flies to humans.

Authors:  Aliza K De Nobrega; Lisa C Lyons
Journal:  Eur J Neurosci       Date:  2018-10-30       Impact factor: 3.386

Review 9.  Circadian rhythms of liver physiology and disease: experimental and clinical evidence.

Authors:  Yu Tahara; Shigenobu Shibata
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

10.  Quantitative Systems Pharmacology: A Framework for Context.

Authors:  Ioannis P Androulakis
Journal:  Curr Pharmacol Rep       Date:  2016-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.